The Amplatzer™ portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The closure procedures are performed through a transcatheter approach, which prevents the need for open heart surgery and enables faster recovery times.
The Amplatzer Family of Duct Occluders offers an extensive line of devices and a simple treatment option for the closure of patent ductus arteriosus (PDA). Amplatzer™ Duct Occluders are designed to occlude PDAs of various shapes and sizes. With an easy-to-perform deployment procedure, the implanting physician can be confident in placing the device with precision.
The Amplatzer™ Talisman™ PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke. It’s the leading PFO closure device to date, with over 180,000 devices implanted worldwide.5
MAT-2008012 v3.0 | Item approved for OUS use only.
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?